This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
FAM212B Polyclonal Antibody
catalog :
PA5-70353
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
rat
application :
western blot
product information
Product Type :
Antibody
Product Name :
FAM212B Polyclonal Antibody
Catalog # :
PA5-70353
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Affinity chromatography
Host :
Rabbit
Reactivity :
Rat
Applications :
Western Blot: 1.0 ug/mL
Species :
Rat
Isotype :
IgG
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
FAM212B (INKA2, Inka Box Actin Regulator 2) is a Protein Coding gene. An important paralog of this gene is ENSG00000284755. Inhibitor of the serine/threonine-protein kinase PAK4. Acts by binding PAK4 in a substrate-like manner, inhibiting the protein kinase activity.
Immunogen :
synthetic peptide directed towards the middle region of human FAM212B
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1.0 ug/mL
Aliases :
6530418L21Rik; C1orf183; C3H1orf183; FAM212B; family with sequence similarity 212 member B; family with sequence similarity 212, member B; HInca-r; Induced in neural crest by AP2-alpha protein-related homolog; Inka box actin regulator 2; Inka2; MInca-r; PAK4-inhibitor INKA2; protein FAM212B; RGD1306526; uncharacterized protein C1orf183 homolog
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments